The standard clinical procedure for diagnosing prostate cancer (PCa) is a systematic transrectal ultrasound-guided (TRUS) biopsy, indicated by an elevated prostate-specific antigen (PSA) level and/or an abnormal digital rectal examination (DRE) [1]. The gene discussed is KLK3; the disease is Familial prostate cancer.